Medical Science News

RSS

Discovery might improve design, effectiveness of anti-cancer drugs

Working with an enzyme that degrades anti-cancer drugs in humans, University of North Carolina at Chapel Hill biochemists and colleagues have made a discovery that they believe eventually could help improve such drugs’ design and effectiveness.

18 Oct 2004

Genetic science gaining momentum by silencing genes

Along with five European academic laboratories, researchers from the Flanders Interuniversity Institute for Biotechnology (VIB) connected to Ghent University are accelerating the study of the model plant Arabidopsis thaliana.

16 Oct 2004

Discovery of naturally occurring RNA "switches" that manage the amino acid glycine

Two University of Washington computer scientists are part of a team that has discovered a pair of rare, naturally occurring RNA "switches" in a class of bacteria that work cooperatively to manage the amino acid glycine.

11 Oct 2004

Carbon nanotubes offer a new approach to gene therapy

Many genes that are related to particular diseases have now been identified. Scientists are trying to use this knowledge to treat diseases.

11 Oct 2004

Discovery could lead to the creation of naturally decaffeinated coffee plants

Chemists at Emory University have made an important advance in harnessing the ability of bacteria to make new molecules, and their discovery could eventually lead to the creation of naturally decaffeinated coffee plants.

10 Oct 2004

Discovery of the oldest remains of a woman who died in childbirth

In ancient times, female death rates were particularly high and generally related to problems in maternity, such as complications during pregnancy, childbirth or the period of breast-feeding.

6 Oct 2004

A new biodegradable material which could help treat spinal injuries without invasive surgery

A new biodegradable material which could help regenerate spinal cord tissue without invasive surgery is being developed by Monash University PhD student, Ms Rosalyn Jackson.

6 Oct 2004

Compound derived from fruit and vegetables could be used to improve the effects of an established cancer drug

The drug, mitomycin C (MMC), is a well-known anticancer treatment used mainly against solid tumours in the bladder and lower bowel. It is activated by enzymes naturally found in the human body, but its use is limited by severe side effects at higher doses.

5 Oct 2004

Significant progress in development of an animal model of smallpox that closely resembles human disease

Scientists have made significant progress in developing an animal model of smallpox that closely resembles human disease, which will be necessary for testing of future vaccines and potential treatments.

5 Oct 2004

Scientists have shown that the textbook explanation of how enzymes work is wrong

Their discovery may explain why attempts to make artificial enzymes have often been disappointing. Industry must now re-think the rationale for the design of biological catalysts and its approaches to drug design.

5 Oct 2004

Fourth gene found for distal muscular dystrophy

MDA grantees Peter Hedera, a neurologist at Vanderbilt University in Nashville, Tenn., and Nigel Laing, a molecular biologist at the University of Western Australia, were part of a team that identified a fourth gene that, when flawed, leads to distal muscular dystrophy (DD).

4 Oct 2004

South American knife fish may hold one of the keys to our understanding the development of the human brain

Do South American knife fish hold one of the keys to our understanding the development of the human brain? They might, according to Dr. Kent Dunlap, associate professor of biology at Trinity College.

4 Oct 2004

Scientists develop rapid-fire tests for botulinum toxin

Scientists at the University of Wisconsin-Madison have developed a pair of rapid-fire tests for botulinum toxin, a feat that could underpin new technologies to thwart bioterrorism and spur the development of agents to blunt the toxic action of the world's most poisonous substance.

29 Sep 2004

DuPont CEO says consumers will increasingly depend on biotechnology

DuPont Chairman and Chief Executive Officer Charles O. Holliday, Jr. today said significant progress has been made in demonstrating the benefits of biotechnology, in its acceptance, and in the advancement of new and exciting products the technology is making possible.

28 Sep 2004

Medical Science News

Discovery might improve design, effectiveness of anti-cancer drugs

Genetic science gaining momentum by silencing genes

Discovery of naturally occurring RNA "switches" that manage the amino acid glycine

Carbon nanotubes offer a new approach to gene therapy

Discovery could lead to the creation of naturally decaffeinated coffee plants

Discovery of the oldest remains of a woman who died in childbirth

A new biodegradable material which could help treat spinal injuries without invasive surgery

Compound derived from fruit and vegetables could be used to improve the effects of an established cancer drug

Significant progress in development of an animal model of smallpox that closely resembles human disease

Scientists have shown that the textbook explanation of how enzymes work is wrong

Fourth gene found for distal muscular dystrophy

South American knife fish may hold one of the keys to our understanding the development of the human brain

Scientists develop rapid-fire tests for botulinum toxin

DuPont CEO says consumers will increasingly depend on biotechnology

Researchers reduce the toxicity of water-soluble buckyballs by a factor of more than ten million

Replication timing assays may allow much earlier cancer detection

Gene responsible for a rare form of dystonia known as rapid-onset dystonia parkinsonism identified

First generation of human retinal cells in the laboratory from human embryonic stem cells

Breakthrough discovery on why the malaria parasite has become resistant to chloroquine

Genes in poppy could hold the key to producing improved pain management pharmaceuticals

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News